Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus
PaperCitations, authors & open-access status
A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 597 citations, 2009 year and bronze oa status.
597
Citations
2009
Year
bronze
OA Status